Under active development. Data is being added and corrected on an hourly basis.

← Back to Peptides
Hexarelin structure

Hexarelin

Growth Hormone
Phase 2 Research
45%
Low-Moderate Risk
2/5

Dosing Protocol

Typical Dose 100 mcg
Range 100 - 200 mcg
Maintenance 100 mcg 2-3x daily
Cycle 4w on / 4w off

Pharmacokinetics

Half-Life 1.2 hrs
Onset 10 min
Peak 30 min
Duration 2.5 hrs
Bioavailability 95%
Primary Route Subcutaneous

Administration

Routes Subcutaneous, Intravenous
Injection Sites Abdomen, Thigh, Deltoid
Needle Gauge 29-31G
Syringe Type Insulin
Timing Before Bed, Fasted, Post-Workout

Reconstitution

Diluent Bacteriostatic Water
Volume 2 mL
Concentration 2500 mcg/mL
Stability 21 days refrigerated
Vial Sizes 5 mg

Special Instructions

Most potent GHRP but desensitizes after 4-6 weeks. Cycle 4 weeks on, 4 weeks off. Has cardioprotective effects.